Results 41 to 50 of about 1,630,140 (194)

Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study

Lipids in Health and Disease, 2018
Background Preeclampsia is a life-threatening disease in pregnancy, and its complex pathomechanisms are poorly understood. In preeclampsia, lipid metabolism is substantially altered.
Christine Contini, Martin Jansen, Brigitte König, Filiz Markfeld-Erol, Mirjam Kunze, Stefan Zschiedrich, Ulrich Massing, Irmgard Merfort, Heinrich Prömpeler, Ulrich Pecks, Karl Winkler, Gerhard Pütz   +11 more
doaj   +1 more source

National heart, lung, and blood institute state of the science symposium in therapeutic apheresis—Therapeutic apheresis in cardiovascular disease

, 2015
The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well ...
Wu, Yanyun, Winters, Jeffrey L., Moriarty, Patrick M., Patrick M. Moriarty, Yanyun Wu, Ratcliffe, Nora R., Nora R. Ratcliffe, Jeffrey L. Winters, Cooper, Leslie T., Leslie T. Cooper   +9 more
core   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense, Nicole Bavaro, Aashna Farishta, Jiaqi Chen, Raj Chovatiya   +4 more
wiley   +1 more source

The Italian Registry of Therapeutic Apheresis: Granulocyte_Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease. A Multicentric Study

, 2011
The Italian Registry of Therapeutic Apheresis: Granulocyte-Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease.
Di Leo V, Saladino V, Repaci G, D'Ovidio V, Astegiano M, Valpiani D, Costa F, Santini A, Testa R, Silla M., Lecis P, Aratari A, Guidi ML, Bresci G, RICCI, Chiara, Riegler G, Calella F, Marco M, D'Incà R, Sablich R, Principi M, Colombo E, Armuzzi A, Passalacqua S, Ferraro PM, Cavallaro F   +25 more
core   +1 more source

Successful Therapeutic Leukapheresis in a Patient of Lobar Pneumonia with Hyperleukocytosis: A Case Report

Global Journal of Transfusion Medicine
Hyperleukocytosis is a rare and potentially life-threatening condition that can cause leukostasis and organ dysfunction. This case report describes the case of a 69-year-old female who presented with fever, drowsiness, and consolidation in the left lung ...
Anshika Yadav, Rounak Dubey, Gajendra Nath Gupta   +2 more
doaj   +1 more source

Allergen‐Functionalized Microfluidic Immunoadsorption Platform for Selective Depletion of Peanut‐Specific Antibodies From Whole Blood

Journal of Polymer Science, EarlyView.
We present a microfluidic immunoadsorption platform functionalized with a layer‐by‐layer (LbL) nanofilm composed of poly(diallyldimethylammonium chloride) (PDDA) and protein extract (PE) for selective capture of peanut‐specific antibodies directly from the whole blood obtained from a peanut allergy mouse model.
Hesaneh Ahmadi, Nur Hendri Wahyu Firdaus, Rutwik Joshi, Akhilesh Kumar Shakya, Wei Li   +4 more
wiley   +1 more source

THERAPEUTIC APHERESIS FOR EPIDERMOLYSIS BULLOSA AND SECONDARY THROMBOCYTOSIS IN NORWEGIAN SCABIES: A CASE REPORT

Hematology, Transfusion and Cell Therapy
Introduction: Secondary thrombocytosis is a well-recognized response to chronic inflammation, infections, and systemic disorders, but its association with dermatologic diseases such as Norwegian scabies and epidermolysis bullosa is rare.
Mine Ezgi Payaslı, Gökhan Demirci, Zeliha Yıldız Kandemir, Birol Güvenç   +3 more
doaj   +1 more source

Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency

Frontiers in Medicine, 2021
Background: Thrombocytosis is a common symptom in myeloproliferative neoplasms (MPN), and excessive proliferation may deteriorate into thrombosis, bleeding, myelofibrosis, and may ultimately convert to acute leukemia.
Hongqiang Jiang, Yanxia Jin, Yanxia Jin, Yufeng Shang, Guolin Yuan, Dandan Liu, Jianfang Li, Cong Wang, Lu Ding, Xiqin Tong, Shishang Guo, Fayun Gong, Fuling Zhou   +12 more
doaj   +1 more source

Therapeutic plasma exchange performed in tandem with hemodialysis without supplemental calcium in the apheresis circuit

, 2017
Therapeutic plasma exchange (TPE) and hemopoietic progenitor cell (HPC) collection are apheresis procedures that can safely be performed in tandem with hemodialysis. Despite the return of citrate-anticoagulated blood to the patient during HPC collection,
Hickson, Elda, Greene, Mindy, Bailey, Jeffrey A., Vauthrin, Michelle, Haynes, Stefanie, Zhao, Yong, Ibrahim, Hiba, Weinstein, Robert, Linden, Jeanne   +8 more
core   +1 more source